Myxoma MRI: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Myxoma}} | {{Myxoma}} | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} {{AAM}} | {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} {{AAM}}{{MV}} | ||
==Overview== | ==Overview== | ||
On Magnetic Resonance Imaging (MRI) or ''Cardiac Magenetic Resonance(CMR)'', cardiac myxoma is characterized by a [[soft tissue]] mass within the [[cardiac chambers]] isointense to [[skeletal muscle]]. This imaging modality,plays an important role in the evaluation of cardiac masses and is of great value when echocardiographic findings are suboptimal or when the lesion has an atypical location or appearance. <ref name="pmid">{{cite journal |vauthors=Grebenc ML, Rosado-de-Christenson ML, Green CE, Burke AP, Galvin JR |title=Cardiac myxoma: imaging features in 83 patients |journal=Radiographics |volume=22 |issue=3 |pages=673–89 |year=2002 |pmid= |doi=10.1148/radiographics.22.3.g02ma02673 |url=}}</ref> | On Magnetic Resonance Imaging (MRI) or ''Cardiac Magenetic Resonance(CMR)'', cardiac myxoma is characterized by a [[soft tissue]] mass within the [[cardiac chambers]] isointense to [[skeletal muscle]]. This imaging modality, plays an important role in the evaluation of cardiac masses and is of great value when echocardiographic findings are suboptimal or when the lesion has an atypical location or appearance. <ref name="pmid">{{cite journal |vauthors=Grebenc ML, Rosado-de-Christenson ML, Green CE, Burke AP, Galvin JR |title=Cardiac myxoma: imaging features in 83 patients |journal=Radiographics |volume=22 |issue=3 |pages=673–89 |year=2002 |pmid= |doi=10.1148/radiographics.22.3.g02ma02673 |url=}}</ref> | ||
==MRI== | ==MRI== | ||
On magnetic resonance imaging cardiac myxoma | On magnetic resonance imaging cardiac myxoma characterized by a soft tissue mass within the [[cardiac chambers]] isointense to skeletal muscle: | ||
<div align="left"> | <div align="left"> |
Revision as of 16:50, 25 November 2015
Myxoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Myxoma MRI On the Web |
American Roentgen Ray Society Images of Myxoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Ahmad Al Maradni, M.D. [3]Maria Fernanda Villarreal, M.D. [4]
Overview
On Magnetic Resonance Imaging (MRI) or Cardiac Magenetic Resonance(CMR), cardiac myxoma is characterized by a soft tissue mass within the cardiac chambers isointense to skeletal muscle. This imaging modality, plays an important role in the evaluation of cardiac masses and is of great value when echocardiographic findings are suboptimal or when the lesion has an atypical location or appearance. [1]
MRI
On magnetic resonance imaging cardiac myxoma characterized by a soft tissue mass within the cardiac chambers isointense to skeletal muscle:
-
Axial T1-weighted MRI shows a soft tissue mass within the left atrium isointense to skeletal muscle (arrowheads). A friable myxoma was removed from the left atrium of a 53-year-old man with cerebrovascular accidents.
Cardiac MRI in myxoma
ACC/AHA Guidelines- ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance[2] (DO NOT EDIT)
“ |
CMR may be used for clinical evaluation of cardiac masses, extracardiac structures, and involvement and characterization of masses in the differentiation of tumors from thrombi. |
” |
References
- ↑ Grebenc ML, Rosado-de-Christenson ML, Green CE, Burke AP, Galvin JR (2002). "Cardiac myxoma: imaging features in 83 patients". Radiographics. 22 (3): 673–89. doi:10.1148/radiographics.22.3.g02ma02673.
- ↑ American College of Cardiology Foundation Task Force on Expert Consensus Documents. Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA; et al. (2010). "ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents". Circulation. 121 (22): 2462–508. doi:10.1161/CIR.0b013e3181d44a8f. PMC 3034132. PMID 20479157.